BrainsWay Ltd. (BWAY)
NASDAQ: BWAY · Real-Time Price · USD
9.99
-0.03 (-0.30%)
Oct 29, 2024, 4:00 PM EDT - Market closed
BrainsWay Market Cap
BrainsWay has a market cap or net worth of $165.76 million as of October 29, 2024. Its market cap has increased by 181.90% in one year.
Market Cap
165.76M
Enterprise Value
117.35M
1-Year Change
181.90%
Ranking
Category
Stock Price
$9.99
Market Cap Chart
Since April 17, 2019, BrainsWay's market cap has increased from $120.00M to $165.76M, an increase of 38.13%. That is a compound annual growth rate of 6.01%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 28, 2024 | 166.50M | 55.46% |
Dec 29, 2023 | 107.10M | 158.07% |
Dec 30, 2022 | 41.50M | -64.16% |
Dec 31, 2021 | 115.80M | 38.19% |
Dec 31, 2020 | 83.80M | -20.57% |
Dec 31, 2019 | 105.50M | -12.08% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Checkpoint Therapeutics | 165.67M |
Black Diamond Therapeutics | 164.99M |
MultiPlan | 164.82M |
Adverum Biotechnologies | 164.74M |
Tenaya Therapeutics | 164.09M |
Ventyx Biosciences | 163.25M |
biote | 162.41M |
Leap Therapeutics | 158.80M |